Quidel | QDEL - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
Agilent USD 442M 1000K 2025-09
Avanos Medical USD -1.2M 74.7M 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bruker USD -72.6M 73.1M 2025-09
Cerus USD -20.76M 17.9M 2024-12
Charles River Laboratories USD 170.03M 98.62M 2025-09
Danaher USD 1.24B 138M 2026-03
Haemonetics USD 59.97M 8.69M 2025-12
Illumina USD 220M 86M 2025-09
IQVIA Holdings USD 537M 5.62B 2025-12
Merit Medical Systems USD 73.18M 29.8M 2025-09
Mettler Toledo International USD 269.24M 20.58M 2025-09
Myriad Genetics USD 4.6M 3.4M 2025-12
Neogen USD 28M 15.81M 2025-09
OraSure Technologies USD -18.43M 5.14M 2025-12
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Quidel USD -756.9M 527.3M 2025-09
Revvity USD 55.68M 115.97M 2025-09
STAAR Surgical USD 18.79M 44.7M 2025-09
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Waters USD 170.12M 7.57M 2025-09